International Clinical Trial: Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530666) titled 'Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia' on April 1.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Dartsbio Pharmaceuticals Ltd.

Condition: Cancer Cachexia

Intervention: Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection Drug: DS010 injection

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of Firs...